亚太实验室制定了到 2028 年的测试市场预测 - 按类型（临床生物化学、重症监护、血液学、微生物学、分子诊断、免疫学和其他测试类型）和应用（学术机构、临床研究组织、医院实验室、专科诊断中心等）
市场介绍
实验室开发的测试 (LDT) 是一种体外诊断测试，设计和使用于一个实验室。这些测试可用于估计或区分来自人体解剖学样本的各种分析物材料，例如蛋白质、葡萄糖或胆固醇等化合物或 DNA。实验室和药房自动化体外诊断 (IVD) 方法的扩展预计将推动这一增长，以提供精确、无差错的分析。
市场概况和动态
亚太地区实验室开发的测试市场预计将达到 4,028.17 美元从 2021 年的 23.7268 亿美元到 2028 年增加 100 万美元；预计 2021 年至 2028 年复合年增长率为 7.9%。市场增长的关键因素是癌症和遗传性疾病发病率的增加以及实验室流程自动化程度的提高全球。然而，不断变化的监管环境正在阻碍亚太实验室开发测试市场的增长。
自动化正在成为一种尽量减少人类参与实验室流程的方法。借助专用工作站和系统软件，常规实验室程序的自动化有助于提高效率并减少人为错误。实验室越来越多地采用实验室信息管理系统 (LIMS) 和其他自动化工具来保持严格的法规遵从性、提高效率和生产力并增强数据安全性和完整性。根据发表在《实验室自动化杂志》上的研究，全自动、半自动和手动操作的错误频率分别为 1-5%、1-10% 和 10-30%。此外，实验室系统生成的大量数据引发了对有效数据处理、分析和共享方法的需求，从而凸显了对 LIMS 等高效且具有成本效益的解决方案的需求。 LDT 的自动化可以显着提高生产力并简化合规程序。临床实验室面临着管理不断增加的测试量和进行更复杂的诊断分析的巨大压力，这进一步凸显了对灵活自动化系统的需求。许多医疗科技公司正在提供自动化解决方案来帮助简化临床实验室流程。例如，Roche Cobas Omni–Utility Channel 对于 IVD 测定和大容量 LDT 都是有益的。它旨在满足实验室对高效工作流程日益增长的需求，因为它可以在从样品处理到快速数据解释的不同阶段提供帮助。 3小时内可运行多达96个结果，8小时内可运行多达864个结果，从而提高实验室的效率。此外，癌症发病率的上升以及人们对早期诊断重要性的认识不断提高，正在促进 LDT 的采用。
COVID-19 的爆发将诊断推向了医疗保健的最前沿并提高了全球对质量测试的认识。亚太地区许多国家采取了非常措施，通过提高检测能力来控制感染。例如，新的《医疗器械管理监督条例》 2021年3月，中国发布了739 LDT令，允许开发实验室开发的检测（LDT）。这项新规定放宽了中国对LDT的限制——允许中国医疗机构在一定条件下开发其IVD试剂。此外，政府对 LDT 法规的放松也进一步推动了该地区的市场增长。此外，市场参与者不断推出的产品也进一步推动了市场的增长。因此，此类发展将推动亚太地区实验室开发的测试市场的发展。
关键细分市场
亚太实验室开发的测试市场按类型细分为临床生化、重症监护、血液学、微生物学、分子诊断、免疫学和其他测试类型。血液学部分又细分为凝血和止血、血红蛋白检测、血细胞计数检测等。分子诊断领域预计将在 2021 年占据最大的市场份额。然而，血液学领域预计在预测期内复合年增长率最高。
亚太实验室发达的检测市场按应用分为学术机构、临床研究机构、医院实验室、专科诊断中心等。医院实验室细分市场预计将在 2021 年占据最大的市场份额。然而，预计专科诊断中心细分市场在预测期内的复合年增长率最高。
主要来源和列出的公司
一些在准备亚太实验室开发的测试市场报告时提到的主要和次要来源是中国食品药品监督管理局 (CFDA)、厚生劳动省 (MHLW) 和国家癌症研究所 (NCI)。
购买报告的理由
- 根据亚太实验室开发的测试市场的详细趋势分析确定潜在投资领域 span>未来几年。
- 深入了解推动不同成瘾疗法需求的潜在因素成瘾疗法 支出最高的国家/地区的细分市场，并确定每个国家/地区提供的机会。
- 加强您对市场需求驱动因素、行业趋势和最新技术的了解发展等。
- 确定推动亚太地区地尔硫卓市场的主要渠道 清晰地描绘未来的机会，这将有助于分析，从而增加收入。
- 通过关注不同国家/地区正在进行的项目来引导资源 亚太实验室开发的测试市场。
亚太实验室开发的测试市场细分
按类型
- 临床生物化学
- 重症监护
- 血液学
- 凝血和止血，
- 血红蛋白测试
- 血细胞计数检测
- 其他
- 免疫学
- 微生物学
- 分子诊断
- 其他测试类型
按应用程序
- 学术机构
- 临床研究机构
- 医院实验室
- 专科诊断中心
- 其他
由国家/地区
- 印度
- 日本
- < span>中国
- 韩国
- 澳大利亚
- 其他地区亚太地区
公司简介
- Quest Diagnostics Incorporated
- F. HOFFMANN-LA ROCHE LTD.
- QIAGEN
- Illumina, Inc.
- 欧陆科技
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Laboratory Developed Test Market – By Type
1.3.2 Asia Pacific Laboratory Developed Test Market – By Application
1.3.3 Asia Pacific Laboratory Developed Test Market – By Country
2. Laboratory Developed Test Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Laboratory Developed Test Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific – PEST Analysis
4.3 Experts Opinion
5. Laboratory Developed Test Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Cancer and Genetic Disorders
5.1.2 Large Number of Product Launches
5.2 Market Restraints
5.2.1 Changing Regulatory Landscape
5.3 Market Opportunities
5.3.1 Continuous Research on Personalized Medicine
5.4 Future Trends
5.4.1 Automation of Laboratory Processes
5.5 Impact Analysis
6. Laboratory Developed Test Market –Asia Pacific Analysis
6.1 Asia Pacific Laboratory Developed Test Market Revenue Forecast and Analysis
7. Laboratory Developed Test Market Analysis – By Type
7.1 Overview
7.2 Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)
7.3 Clinical Biochemistry
7.3.1 Overview
7.3.2 Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Haematology
7.4.1 Overview
7.4.2 Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Coagulation and Hemostasis
7.4.3.1 Overview
7.4.3.2 Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Hemoglobin Testing
7.4.4.1 Overview
7.4.4.2 Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Blood Count Testing
7.4.5.1 Overview
7.4.5.2 Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.6 Others
7.4.6.1 Overview
7.4.6.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Immunology
7.5.1 Overview
7.5.2 Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Critical Care
7.6.1 Overview
7.6.2 Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Microbiology
7.7.1 Overview
7.7.2 Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Molecular Diagnostics
7.8.1 Overview
7.8.2 Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Other Test Types
7.9.1 Overview
7.9.2 Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8. Laboratory Developed Test Market Analysis – By Application
8.1 Overview
8.2 Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)
8.3 Academic Institutes
8.3.1 Overview
8.3.2 Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Clinical Research organizations
8.4.1 Overview
8.4.2 Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Hospital laboratory
8.5.1 Overview
8.5.2 Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Specialty Diagnostic Centers
8.6.1 Overview
8.6.2 Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
9. Laboratory Developed Test Market – Asia Pacific Analysis
9.1 Asia Pacific: Laboratory Developed Test Market
9.1.1 Overview
9.1.3 Asia Pacific: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)
9.1.3.1 China: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.1.1 China: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.1.2 China: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.1.2.1 China: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.1.3 China: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.2 Japan: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.2.1 Japan: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.2.2 Japan: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.2.2.1 Japan: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.2.3 Japan: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.3 India: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.3.1 India: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.3.2 India: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.3.2.1 India: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.3.3 India: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.4 Australia: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.4.1 Australia: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.4.2 Australia: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.4.2.1 Australia: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.4.3 Australia: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.5 South Korea: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.5.1 South Korea: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.5.2 South Korea: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.5.2.1 South Korea: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.5.3 South Korea: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.5.4 South Korea: Laboratory Developed Test Market, by End User, 2019–2028 (USD Million)
9.1.3.6 Rest of Asia Pacific: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.6.1 Rest of Asia Pacific: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.6.2 Rest of Asia Pacific: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.6.2.1 Rest of Asia Pacific: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.6.3 Rest of Asia Pacific: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Laboratory Developed Test Market
10.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11. Laboratory Developed Test Market–Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Quest Diagnostics Incorporated
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F.HOFFMANN-LA ROCHE LTD.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Illumina, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Eurofins Scientific
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Incidence Rate Of Cancer in 2018 in China
Table 2. China: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 3. China Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 4. China: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 5. Japan: Laboratory Developed Test Market, By Type– Revenue and Forecast to 2028 (USD Million)
Table 6. Japan Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 7. Japan: Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 8. India: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 9. India Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 10. India: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 11. Australia: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Australia Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 13. Australia: Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 14. South Korea: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 15. South Korea Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 16. South Korea: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 17. South Korea: Laboratory Developed Test Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Asia Pacific: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Asia Pacific Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 20. Rest of Asia Pacific: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 21. Recent Inorganic Growth Strategies in the Laboratory Developed Test Market
Table 22. Recent Organic Growth Strategies in the Laboratory Developed Test Market
Table 23. Glossary of Terms, Laboratory Developed Test Market
LIST OF FIGURES
Figure 1. Laboratory Developed Test Market Segmentation
Figure 2. Laboratory Developed Test Market Segmentation, By Country
Figure 3. Asia Pacific Laboratory Developed Test Market Overview
Figure 4. Molecular Diagnostics Segment Held the Largest Share of the Type Segment in Laboratory Developed Test Market
Figure 5. Asia Pacific Laboratory Developed Test Market – Leading Country Markets (US$ Million)
Figure 6. Asia Pacific PEST Analysis
Figure 1. Laboratory Developed Test Market Impact Analysis of Drivers and Restraints
Figure 2. Asia Pacific Laboratory Developed Test Market – Revenue Forecast and Analysis – 2020- 2028
Figure 3. Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)
Figure 4. Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 5. Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 6. Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 7. Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 8. Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 9. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)
Figure 16. Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Asia Pacific: Laboratory Developed Test Market, by Key Country – Revenue (2021) (USD Million)
Figure 22. Asia Pacific: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)
Figure 23. China: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 24. Japan: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. India: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Australia: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. South Korea: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Rest of Asia Pacific: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- Quest Diagnostics Incorporated
- F. HOFFMANN-LA ROCHE LTD.
- QIAGEN
- Illumina, Inc.
- Eurofins Scientific
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific laboratory developed test market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific laboratory developed test market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.